c-Jun N-terminal kinase negatively regulates dsRNA and RSV induction of tumor necrosis factor-α transcription in human epithelial cells

Journal of Interferon and Cytokine Research

Volumn 26, Issue 8, 2006, Pages 521-533

  Stewart, Michael J ^a   Kulkarni, Sandhya B ^b   Meusel, Tiffany R ^b   Imani, Farhad ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b JOHNS HOPKINS ASTHMA AND ALLERGY CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE R; STRESS ACTIVATED PROTEIN KINASE; TOLL LIKE RECEPTOR 3; TRANSCRIPTION FACTOR AP 1; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME INHIBITION; EPITHELIUM CELL; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; INNATE IMMUNITY; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; VIRUS INDUCTION; VIRUS INFECTION;

ANTHRACENES; CELL LINE; EPITHELIAL CELLS; GENE EXPRESSION REGULATION; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MUTATION; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN KINASE INHIBITORS; RESPIRATORY MUCOSA; RESPIRATORY SYNCYTIAL VIRUSES; RNA, DOUBLE-STRANDED; TRANSCRIPTION, GENETIC; TUMOR NECROSIS FACTOR-ALPHA;

RICE STRIPE VIRUS;

EID: 33747888284     PISSN: 10799907     EISSN: None     Source Type: Journal    
DOI: 10.1089/jir.2006.26.521     Document Type: Article

References (67)

1. Subauste MC, Jacoby DB, Richards SM, Proud D. Infection of a human respiratory epithelial cell line with rhinovirus. Induction of cytokine release and modulation of susceptibility to infection by cytokine exposure. J. Clin. Invest. 1995;96:549-557.
2. Bosch I, Xhaja K, Estevez L, Raines G, Melichar H, Warke RV, Fournier MV, Ennis FA, Rothman AL. Increased production of interleukin-8 in primary human monocytes and in human epithelial and endothelial cell lines after dengue virus challenge. J. Virol. 2002;76:5588-5597.
3. Konno S, Grindle KA, Lee WM, Schroth MK, Mosser AG, Brockman-Schneider RA, Busse WW, Gern JE. Interferon-gamma enhances rhinovirus-indnced RANTES secretion by airway epithelial cells. Am. J. Respir. Cell. Mol. Biol. 2002;26:594-601.
4. Helin E, Vainionpaa R, Hyypia T, Julkunen I, Matikainen S. Measles virus activates NF-kappa B and Stat transcription factors and production of IFN-alpha/beta and IL-6 in the human lung epithelial cell line A549. Virology 2001;290:1-10.
5. Message SD, Johnston SL. The immunology of virus infection in asthma. Eur. Respir. J. 2001;18:1013-1025.
6. Ammit AJ, Lazaar AL, Irani C, O'Neill GM, Gordon ND, Amrani Y, Penn RB, Panettieri RA Jr. Tumor necrosis factor-alpha-induced secretion of RANTHS and interleukin-6 from human airway smooth muscle cells: modulation by glucocorticoids and beta-agonists. Am. J. Respir. Cell. Mol. Biol. 2002;26:465-474.
7. Tang YW, Graham BS. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice. J. Clin. Invest. 1997;99:2183-2191.
8. Garofalo R, Mei F, Espejo R, Ye G, Haeberle H, Baron S, Ogra PL, Reyes VE. Respiratory syncytial virus infection of human respiratory epithelial cells up-regulates class 1 MHC expression through the induction of IFN-beta and IL-1 alpha. J. Immunol. 1996;157:2506-2513
9. Becker S, Quay J, Soukup J. Cytokine (tumor necrosis factor, IL-6, and IL-8) production by respiratory syncytial virus-infected human alveolar macrophages. J. Immunol. 1991;147:4307-4312.
10. Ronni T, Matikainen S, Sareneva T, Melen K, Pirhonen J, Keskinen P, Julkunen I. Regulation of IFN-alpha/beta, MxA, 2′,5′-oligoadenylate synthetase, and HLA gene expression in influenza A-infected human lung epithelial cells. J. Immunol. 1997;158:2363-2374.
11. Choi AM, Jacoby DB. Influenza virus A infection induces interleukin-8 gene expression in human airway epithelial cells. FEBS Lett. 1992;309:327-329.
12. Kehoe KE, Brown MA, Imani F. Double-stranded RNA regulates IL-4 expression. J. Immunol. 2001;167:2496-2501.
13. Meusel TR, Kehoe KE, Imani F. Protein kinase R regulates double-stranded RNA induction of TNF-alpha but not IL-1 beta mRNA in human epithelial cells. J. Immunol. 2002;168:6429-6435.
14. Finkelman FD, Svetic A, Gresser I, Snapper C, Holmes J, Trotta PP, Katona IM, Cause WC. Regulation by interferon alpha of immunoglobulin isotype selection and lymphokine production in mice. J. Exp. Med. 1991;174:1179-1188.
15. Cella M, Salio M, Sakakibara Y, Langen H, Julkunen I, Lanzavecchia A. Maturation, activation, and protection of dendritic cells induced by double-stranded RNA. J. Exp. Med. 1999;189:821-829.
16. de Jong EC, Vieira PL, Kalinski P, Schuitemaker JH, Tanaka Y, Wierenga EA, Yazdanbakhsh M, Kapsenberg ML. Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse Th cell-polarizing signals. J. Immunol. 2002;168:1704-1709.
17. Mota I, Perini A. The effect of a synthetic double-stranded RNA on IgC1 and IgE production by guinea pigs. A comparative study with lipopolysaccharide. Immunology 1975;29:319-326.
18. Rager KJ, Langland JO, Jacobs BL, Proud D, Marsh DG, Imani F. Activation of antiviral protein kinase leads to immunoglobulin E class switching in human B cells. J. Virol. 1998;72:1171-1176.
19. Jacobs BL, Langland JO. When two strands are better than one: the mediators and modulators of the cellular responses to double-stranded RNA. Virology 1996;219:339-349.
20. Doukas J, Cutler AH, Mordes JP. Polyinosinic:polycytidylic acid is a potent activator of endothelial cells. Am. J. Pathol. 1994;145:137-147.
21. Genin P, Algarte M, Roof P, Lin R, Hiscott J. Regulation of RANTES chemokine gene expression requires cooperativity between NF-kappa B and IFN-regulatory factor transcription factors. J. Immunol. 2000;164:5352-5361.
22. Lin R, Heylbroeck C, Genin P, Pitha PM, Hiscott J. Essential role of interferon regulatory factor 3 in direct activation of RANTES chemokine transcription. Mol. Cell. Biol. 1999;19:959-966.
23. De Clercq E, Merigan TC, Finkelstein MS, Bausek GH. Requirement of a stable secondary structure for the antiviral activity of polynucleotides. Nature 1969;222:1148-1152.
24. Goldfeld AE, Doyle C, Maniatis T. Human tumor necrosis factor alpha gene regulation by virus and lipopolysaccharide. Proc. Natl. Acad. Sci. USA 1990;87:9769-9773.
25. Paludan SR, Melchjorsen J, Malmgaard L, Mogensen SC. Expression of genes forcytokines and cytokine-related functions in leukocytes infected with herpes simplex virus: comparison between resistant and susceptible mouse strains. Eur. Cytokine Netw. 2002;13:306-316.
26. Gern JE, French DA, Grindle KA, Brockman-Schneider RA, Konno SI, Busse WW. Double-stranded RNA induces the synthesis of specific chemokines by bronchial epithelial cells. Am. J. Respir. Cell. Mol. Biol. 2002;28:731-737.
27. Meusel TR, Imani F. Viral induction of inflammatory cytokines in human epithelial cells follows a p38 mitogen-activated protein kinase-dependent but NF-kappaB-independent pathway. J. Immunol. 2003;171:3768-3774.
28. Zhou HR, Lau AS, Pestka JJ. Role of double-stranded RNA-activated protein kinase R (PKR) in deoxynivalenol-induced ribotoxic stress response. Toxicol. Sci. 2003;74:335-344.
29. Manning AM, Davis RJ. Targeting JNK for therapeutic benefit: from junk to gold? Nat. Rev. Drug Discov. 2003;2:554-565.
30. Imani F, Jacobs BL. Inhibitory activity for the interferon-induced protein kinase is associated with the reovirus serotype 1 sigma 3 protein. Proc. Natl. Acad. Sci. USA 1988;85:7887-7891.
31. Graham BS, Perkins PM, Wright PF, Karzon DT. Primary respiratory syncytial virus infection in mice. J. Med. Virol. 1988;26:153-162.
32. Kips JC, Tavernier JH, Joos GF, Peleman RA, Pauwels RA. The potential role of tumour necrosis factor alpha in asthma. Clin. Exp. Allergy 1993;23:247-250.
33. Krunkosky TM, Fischer BM, Martin LD, Jones N, Akley NJ, Adler KB. Effects of TNF-alpha on expression of ICAM-1 in human airway epithelial cells in vitro. Signaling pathways controlling surface and gene expression. Am. J. Respir. Cell. Mol. Biol. 2000;22:685-692.
34. Arm JP, Lee TH. The pathobiology of bronchial asthma. Adv. Immunol. 1992;51:323-382.
35. Doherty PC. Cell-mediated cytotoxicity. Cell 1993;75:607-6I2.
36. Kips JC, Tavernier J, Pauwels RA. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am. Rev. Respir. Dis. 1992;145:332-336.
37. Sabapathy K, Hu Y, Kallunki T, Schreiber M, David JP, Jochum W, Wagner EF, Karin M. JNK2 is required for efficient T-cell activation and apoptosis but not for normal lymphocyte development. Curr. Biol. 1999;9:116-125.
38. Kuan CY, Yang DD, Samanta Roy DR, Davis RJ, Rakic P, Flavell RA. The Jnk1 and Jnk2 protein kinases are required for regional specific apoptosis during early brain development. Neuron 1999;22:667-676.
39. Dong C, Davis RJ, Flavell RA. MAP kinases in the immune response. Annu. Rev. Immunol. 2002;20:55-72.
40. Fearns C, Kline L, Gram H, Di Padova F, Zurini M, Han J, Ulevitch RJ. Coordinate activation of endogenous p38alpha, beta, gamma, and delta by inflammatory stimuli. J. Leukoc. Biol. 2000;67:705-711.
41. Tabeta K, Georgel P, Janssen E, Du X, Hoebe K, Crozat K, Mudd S, Shamel L, Sovath S, Goode J, Alexopoulou L, Flavell RA, Beutler B. Toll-like receptors 9 and 3 as essential components of innate immune defense against mouse cytomegalovirus infection. Proc. Natl. Acad. Sci. USA 2004;101:3516-3521.
42. Minks MA, West DK, Benvin S, Baglioni C. Structural requirements of double-stranded RNA for the activation of 2′,5′-oligo(A) polymerase and protein kinase of interferon-treated HeLa cells. J. Biol. Chem. 1979;254:10180-10183.
43. Miyamoto NG, Jacobs BL, Samuel CE. Mechanism of interferon action. Effect of double-stranded RNA and the 5′-O-monophosphate form of 2′,5′-oligoadenylate on the inhibition of reovirus mRNA translation in vitro. J. Biol. Chem. 1983;258:15232-15237.
44. Hovanessian AG, Kerr IM. The (2′-5′) oligoadenylate (pppA2′-5′A2′-5′A) synthetase and protein kinase(s) from interferon-treated cells. Eur. J. Biochem. 1979;93:515-526.
45. Decker T. Double-stranded RNA and interferon-α induce transcription through different molecular mechanisms. J. Interferon Res. 1992;12:445-448.
46. Falvo JV, Parekh BS, Lin CH, Fraenkel E, Maniatis T. Assembly of a functional beta interferon enhanceosome is dependent on ATF-2-c-jun heterodimer orientation. Mol. Cell. Biol. 2000;20:4814-4825.
47. tenOever BR, Servant MJ, Grandvaux N, Lin R, Hiscott J. Recognition of the measles virus nucleocapsid as a mechanism of IRF-3 activation. J. Virol. 2002;76:3659-3669.
48. Au WC, Pitha PM. Recruitment of multiple interferon regulatory factors and histone acetyltransferase to the transcriptionally active interferon-α promoters. J. Biol. Chem. 2001;276:41629-11637.
49. Lin R, Mamane Y, Hiscott J. Multiple regulatory domains control IRF-7 activity in response to virus infection. J. Biol. Chem. 2000;275:34320-34327.
50. Wathelet MG, Lin CH, Parekh BS, Ronco LV, Howley PM, Maniatis T. Virus infection induces the assembly of coordinately activated transcription factors on the IFN-beta enhancer in vivo. Mol. Cell 1998;1:507-518.
51. Kyriakis JM, Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001;81:807-869.
52. Garrington TP, Johnson GL. Organization and regulation of mitogen-activated protein kinase signaling pathways. Curr. Opin. Cell Biol. 1999;11:211-218.
53. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, McNulty D, Blumenthal MJ, Heys JR, Landvatter SW. A protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 1994;372:739-746.
54. Hedges JC, Singer CA, Gerthoffer WT. Mitogen-activated protein kinases regulate cytokine gene expression in human airway myocytes. Am. J. Respir. Cell. Mol. Biol. 2000;23:86-94.
55. Cerami A. Inflammatory cytokines. Clin. Immunol. Immunopathol. 1992;62:S3-10.
56. Kikuchi K, Yanagawa Y, Aranami T, Iwabuchi C, Iwabuchi K, Onoe K. Tumour necrosis factor-alpha but not lipopolysaccharide enhances preference of murine dendritic cells for Th2 differentiation. Immunology 2003;108:42-49.
57. Gauchat JF, Aversa G, Gascan H, de Vries JE. Modulation of IL-4 induced germline epsilon RNA synthesis in human B cells by tumor necrosis factor-alpha, anti-CD40 monoclonal antibodies or transforming growth factor-beta correlates with levels of IgE production. Int. Immunol. 1992;4:397-406.
58. Romagnani S. T-cell subsets (Th1 versus Th2). Ann. Allergy Asthma Immunol. 2000;85:9-18.
59. + T lymphocytes into Th1/Th2 effectors. Vaccine 1998;16:1415-1419.
60. Sledz CA, Holko M, de Veer MJ, Silverman RH, Williams BR. Activation of the interferon system by short-interfering RNAs. Nat Cell. Biol. 2003;5:834-839.
61. Caplen NJ, Parrish S, Imani F, Fire A, Morgan RA. Specific inhibition of gene expression by small double-stranded RNAs in invertebrate and vertebrate systems. Proc. Natl. Acad. Sci. USA 2001;98:9742-9747.
62. Kumar A, Haque J, Lacoste J, Hiscott J, Williams BR. Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proc. Natl. Acad. Sci. USA 1994;91:6288-6292.
63. Ramana CV, Chnernov M, Nguyen H, Goh KC, Williams BR, Stark GR. Regulation of c-myc expression by IFN-gamma through Stat 1-dependent and independent pathways. EMBO J. 2000;19:263-272.
64. Langland JO, Kao PN Jacobs BL. Nuclear factor-90 of activated T-cells: a double-stranded RNA-binding protein and substrate for the double-stranded RNA-dependent protein kinase, PKR. Biochemistry 1999;38:6361-6368.
65. Liang Q, Buno OF, Wilkins BJ, Kuan CY, Xia Y, Molkentin JD. c-Jun N-terminal kinase (JNK) antagonize cardiac growth through cross-talk with calcineurin-NFAT signaling. EMBO J. 2003;22:5079-5089.
66. Hall-Jackson CA, Goedert M, Hedge P, Cohen P. Effect of SB 203580 on the activity of c-Raf in vitro and in vivo. Oncogene 1999;18:2047-2054.
67. Borsch-Haubold AG, Pasquet S, Watson SP. Direct inhibition of cyclooxygenase-1 and -2 by the kinase inhibitors SB 203580 and PD 98059. SB 203580 also inhibits thromboxane synthase. J. Biol. Chem. 1998;273:28766-28772.